$MEND prices continue to establish solidity With the recent award for research in placebo response related to mental health awarded to Nurosene $MEND/$MEND.C CSO, the company appears to have established a reversal in price action into a bullish trend.
As $MEND continues the development of its NURO app, aimed at improving the happiness and healthines of peoples lives, this award shows that the company is establishing some promising methods and practices for the application.
With strong signs of a bottom formation around Christmas time, shares have continued to trend higher showing greater signs of a reversal as time goes on.
As prices continue to establish solidity along the 50MA, I’m keeping a close watch to see if price action can begin to trend above the line and use it as a point of support.
Further news of $MEND’s application development and release dates should provide solid catalysts to push shares further along some bullish movement.
Shares of $MEND are currently trading at $1.01 and the company is valued at an MCAP of $40.54 million.
https://ceo.ca/@newswire/nurosene-cso-awarded-for-research-on-placebo-response